Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'STANDARD HEPARIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 312 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Toss, H; Wallentin, L; Siegbahn, A
      Effects of low-molecular-weight heparin treatment on fibrinolytic markers in unstable coronary artery disease

      FIBRINOLYSIS & PROTEOLYSIS
    2. Bell, GK; Goldhaber, SZ
      Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement

      VASCULAR MEDICINE
    3. Attanasio, E; Russo, P; Carunchio, G; Caprino, L
      Dermatan sulfate versus unfractionated heparin for the prevention of venous thromboembolism in patients undergoing surgery for cancer - A cost-effectiveness analysis

      PHARMACOECONOMICS
    4. Lai, KN; Ho, K; Cheung, RCK; Lit, LCW; Lee, SKM; Fung, KS; Tong, MKL; Lam, CWK
      Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    5. Lopez, LM
      Low-molecular-weight heparins are essentially the same for treatment and prevention of venous thromboembolism

      PHARMACOTHERAPY
    6. Hofmann, S; Knoefler, R; Lorenz, N; Siegert, G; Wendisch, J; Mueller, D; Taut-Sack, H; Dinger, J; Kabus, M
      Clinical experiences with low-molecular weight heparins in pediatric patients

      THROMBOSIS RESEARCH
    7. Bergqvist, D
      Venous thromboembolism and cancer: Prevention of VTE

      THROMBOSIS RESEARCH
    8. Janni, W; Bergauer, F; Rjosk, D; Lohscheidt, K; Hagena, FW
      A randomized controlled study evaluating the safety and efficacy of different low molecular weight heparins for high risk patients

      ZENTRALBLATT FUR CHIRURGIE
    9. Turpie, AGG; Gallus, AS; Hoek, JA
      A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.

      NEW ENGLAND JOURNAL OF MEDICINE
    10. Breddin, HK; Hach-Wunderle, V; Nakov, R; Kakkar, VV
      Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.

      NEW ENGLAND JOURNAL OF MEDICINE
    11. Mismetti, P; Laporte, S; Darmon, JY; Buchmuller, A; Decousus, H
      Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery

      BRITISH JOURNAL OF SURGERY
    12. van Heereveld, HAEM; Laan, RFJM; van den Hoogen, FHJ; Malefijt, MCD; Novakova, IRO; van de Putte, LBA
      Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement

      ANNALS OF THE RHEUMATIC DISEASES
    13. McLeod, RS; Geerts, WH; Sniderman, KW; Greenwood, C; Gregoire, RC; Taylor, BM; Silverman, RE; Atkinson, KG; Burnstein, M; Marshall, JC; Burul, CJ; Anderson, DR; Ross, T; Wilson, SR; Barton, P
      Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery - Results of the Canadian DVT prophylaxis trial: A randomized, double-blind trial

      ANNALS OF SURGERY
    14. Hirsh, J; Bates, SM
      Clinical trials that have influenced the treatment of venous thromboembolism: A historical perspective

      ANNALS OF INTERNAL MEDICINE
    15. Merli, G; Spiro, TE; Olsson, CG; Abildgaard, U; Davidson, BL; Eldor, A; Elias, D; Grigg, A; Musset, D; Rodgers, GM; Trowbridge, AA; Yusen, RD; Zawilska, K
      Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease

      ANNALS OF INTERNAL MEDICINE
    16. Ellison, J; Walker, ID; Greer, IA
      Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    17. Harvey, DM; Offord, RH
      Management of venous and cardiovascular thrombosis: enoxaparin

      HOSPITAL MEDICINE
    18. Wade, WE; Martin, BC; Kotzan, JA; Spruill, WJ; Chisoholm, MA; Perri, M
      Formulary management of low molecular weight heparins

      PHARMACOECONOMICS
    19. Tapson, VF
      Treatment of acute deep venous thrombosis and pulmonary embolism: Use of low molecular weight heparin

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    20. Pacheco, RG; Vicente, CP; Zancan, P; Maurao, PAS
      Different antithrombotic mechanisms among glycosaminoglycans revealed witha new fucosylated chondroitin sulfate from an echinoderm

      BLOOD COAGULATION & FIBRINOLYSIS
    21. Rocha, E; Martinez-Gonzalez, MA; Montes, R; Panizo, C
      Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A mete-analysis

      HAEMATOLOGICA
    22. Harenberg, J; Schmidt, JA; Koppenhagen, K; Tolle, A; Huisman, MV; Buller, HR
      Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis

      THROMBOSIS AND HAEMOSTASIS
    23. Kovacs, MJ; Anderson, D; Morrow, B; Gray, L; Touchie, D; Wells, PS
      Outpatient treatment of pulmonary embolism with dalteparin

      THROMBOSIS AND HAEMOSTASIS
    24. Mismetti, P; Laporte-Simitsidis, S; Tardy, B; Cucherat, M; Buchmuller, A; Juillard-Delsart, D; Decousus, H
      Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: A meta-analysis of randomised clinical trials

      THROMBOSIS AND HAEMOSTASIS
    25. Salbach, PB; Bruckmann, M; Turovets, O; Kreuzer, J; Kubler, W; Walter-Sack, I
      Heparin-mediated selective release of hepatocyte growth factor in humans

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    26. Matzsch, T
      Thromboprophylaxis with low-molecular-weight heparin: Economic considerations

      HAEMOSTASIS
    27. van der Heijden, JF; Prins, MH; Buller, HR
      Low-molecular-weight heparins: Are they interchangeable?

      HAEMOSTASIS
    28. Hedner, U
      Development of tinzaparin: A heparinase-digested low-molecular-weight heparin

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    29. Breddin, HK
      Prophylaxis and treatment of deep-vein thrombosis

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    30. Hull, RD; Pineo, GF
      Low-molecular-weight heparin in the treatment of venous thromboembolism

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    31. Wachsman, M; Mielke, CH; Hayes, JA; Baker, D
      The use of time step simulations and difference equations (TSSADEQ) in modeling heparin pharmacokinetics

      JOURNAL OF CLINICAL PHARMACOLOGY
    32. Crowther, MA; Spitzer, K; Julian, J; Ginsberg, J; Johnston, M; Crowther, R; Laskin, C
      Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients: A prospective cohort study

      THROMBOSIS RESEARCH
    33. Ageno, W
      Treatment of venous thromboembolism

      THROMBOSIS RESEARCH
    34. Boneu, B
      Low molecular weight heparins: Are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis?

      THROMBOSIS RESEARCH
    35. van der Heijden, JF; Prins, MH; Buller, HR
      For the initial treatment of venous thromboembolism: Are all low-molecular-weight heparin compounds the same?

      THROMBOSIS RESEARCH
    36. Maxwell, GL; Myers, ER; Clarke-Pearson, DL
      Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery

      OBSTETRICS AND GYNECOLOGY
    37. Bosch, MM
      Treatment of submasive pulmonary embolism with low-molecular-weight heparin

      MEDICINA CLINICA
    38. Dix, D; Andrew, M; Marzinotto, V; Charpentier, K; Bridge, S; Monagle, P; deVeber, G; Leaker, M; Chan, AKC; Massicotte, MP
      The use of low molecular weight heparin in pediatric patients: A prospective cohort study

      JOURNAL OF PEDIATRICS
    39. Freedman, KB; Brookenthal, KR; Fitzgerald, RH; Williams, S; Lonner, JH
      A meta-analysis of thromboembolic prophylaxis following elective total hiparthroplasty

      JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
    40. Bick, RL
      Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism

      DRUGS
    41. Dolovich, LR; Ginsberg, JS; Douketis, JD; Holbrook, AM; Cheah, G
      A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism - Examining some unanswered questions regarding location of treatment, product type, and dosing frequency

      ARCHIVES OF INTERNAL MEDICINE
    42. Nguyen, HN
      Effectiveness and safety of low-molecular-weight heparin for thrombosis prophylaxis

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    43. Ahmad, S; Jeske, WP; Walenga, JM; Hoppensteadt, DA; Wood, JJ; Herbert, JM; Messmore, HL; Fareed, J
      Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    44. Bick, RL; Frenkel, EP
      Clinical aspects of heparin-induced thrombocytopenia and thrombosis and other side effects of heparin therapy

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    45. Abramson, S; Niles, JL
      Anticoagulation in continuous renal replacement therapy

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    46. Maharaj, S; Bayliff, CD; Kovacs, MJ
      Successful anticoagulation with dalteparin in a patient with mechanical heart valves

      ANNALS OF PHARMACOTHERAPY
    47. Szucs, TD; Schramm, W
      The cost-effectiveness of low-molecular-weight heparin vs unfractionated heparin in general and orthopaedic surgery: An analysis for the German healthcare system

      PHARMACOLOGICAL RESEARCH
    48. ten Cate, JW
      Evolution of therapies in deep vein thrombosis management

      BLOOD COAGULATION & FIBRINOLYSIS
    49. Ageno, W
      Applying risk assessment models in general surgery: overview of our clinical experience

      BLOOD COAGULATION & FIBRINOLYSIS
    50. Turpie, AGG
      Customizing our approach in deep vein thrombosis and pulmonary embolism treatment: overview of our clinical experience

      BLOOD COAGULATION & FIBRINOLYSIS
    51. Linke, LC; Katthagen, BD
      Weight-based heparin dosing is more effective in the treatment of postoperative deep vein thrombosis

      ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
    52. Choussat, R; Montalescot, G
      Low-molecular-weight heparin in unstable angina and infarction without Q wave

      PRESSE MEDICALE
    53. Salartash, K; Gonze, MD; Leone-Bay, A; Baughman, R; Sternbergh, WC; Money, SR
      Oral low-molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat

      JOURNAL OF VASCULAR SURGERY
    54. Marchetti, M; Liberato, NL; Ruperto, N; Barosi, G
      Long term cost-effectiveness of low molecular weight heparin versus unfractionated heparin for the prophylaxis of venous thromboembolism in elective hip replacement

      HAEMATOLOGICA
    55. Holmstrom, M; Aberg, W; Lockner, D; Paul, C
      Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: A retrospective analysis

      THROMBOSIS AND HAEMOSTASIS
    56. Kitchen, S; Iampietro, R; Woolley, AM; Preston, FE
      Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: Inter-assay variability

      THROMBOSIS AND HAEMOSTASIS
    57. Ginsberg, JS
      Thromboembolism and pregnancy

      THROMBOSIS AND HAEMOSTASIS
    58. Hettiarachchi, RJK; Smorenburg, SM; Ginsberg, J; Levine, M; Prins, MH; Buller, HR
      Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread

      THROMBOSIS AND HAEMOSTASIS
    59. Di Carlo, V; Agnelli, G; Prandoni, P; Coccheri, S; Gensini, GF; Gianese, F; Mannucci, PM
      Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer

      THROMBOSIS AND HAEMOSTASIS
    60. Lopaciuk, S; Bielska-Falda, H; Noszczyk, W; Bielawiec, M; Witkiewicz, W; Filipecki, S; Michalak, J; Ciesielski, L; Mackiewicz, Z; Czestochowska, E; Zawilska, K; Cencora, A; Tomkowski, WZ; Hajduk, B; Kloczko, J; Mazgajska, K; Jaromin, J; Chmielecki, Z; Niedziela, P; Czekalski, P; Molski, S; Kwiatkowski, C; Psuja, P; Lewandowski, K; Muszynski, R; Kicinska, M
      Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis

      THROMBOSIS AND HAEMOSTASIS
    61. Nohe, N; Flemmer, A; Rumler, R; Praun, M; Auberger, K
      The low molecular weight heparin dalteparin for prophylaxis and therapy ofthrombosis in childhood: a report on 48 cases

      EUROPEAN JOURNAL OF PEDIATRICS
    62. Beguin, S; Welzel, D; Al Dieri, R; Hemker, HC
      Conjectures and refutations on the mode of action of heparins - The limited importance of anti-factor Xa activity as a pharmaceutical mechanism and ayardstick for therapy

      HAEMOSTASIS
    63. Cuixart, CB; Miralda, GP
      Meta-analysis, megatrials and clinical practice in cardiology

      REVISTA ESPANOLA DE CARDIOLOGIA
    64. Deuber, HJ
      Experience with the fractionated heparin dalteparin in hemodialysis

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    65. Legere, BM; Dweik, RA; Arroliga, AC
      Venous thromboembolism in the intensive care unit

      CLINICS IN CHEST MEDICINE
    66. Smorenburg, SM; Vink, R; te Lintelo, M; Tigchelaar, W; Maas, A; Buller, HR; van Noorden, CJF
      In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis

      CLINICAL & EXPERIMENTAL METASTASIS
    67. Turpie, AGG
      Antithrombotic therapy in the new millennium - the role of low-molecular-weight heparin

      SOUTH AFRICAN MEDICAL JOURNAL
    68. Hovanessian, HC
      New-generation anticoagulants: The low molecular weight heparins

      ANNALS OF EMERGENCY MEDICINE
    69. Zunker, P; Schick, A; Padro, T; Kienast, J; Phillips, A; Ringelstein, EB
      Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: Relation to stroke etiology

      NEUROLOGICAL RESEARCH
    70. Bernat, A; Savi, P; Lale, A; Hoffmann, P; Herbert, JM
      The antithrombotic efficacy of the GP IIb/IIIa antagonist SR121787 is potentiated by antithrombin-dependent factor Xa inhibition without an increase in the bleeding risk in the rabbit

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    71. Gouin-Thibault, I; Samama, MM
      Laboratory diagnosis of the thrombophilic state in cancer patients

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    72. Reeves, JH; Cumming, AR; Gallagher, L; O'Brien, JL; Santamaria, JD
      A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration

      CRITICAL CARE MEDICINE
    73. Young, E; Venner, T; Ribau, J; Shaughnessy, S; Hirsh, J; Podor, TJ
      The binding of unfractionated heparin and low molecular weigh heparin to thrombin-activated human endothelial cells

      THROMBOSIS RESEARCH
    74. Wade, WE; Chisholm, MA
      Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients

      THROMBOSIS RESEARCH
    75. Lamy, O; Cornuz, J; Yersin, B
      Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis: a systematic review

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    76. Sarmiento, A; Goswami, ADK
      Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty

      JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
    77. Ho, YH; Seow-Choen, F; Leong, A; Eu, KW; Nyam, D; Teoh, MK
      Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients

      DISEASES OF THE COLON & RECTUM
    78. Heit, JA
      Risks vs benefits in total joint surgery

      CHEST
    79. Yusen, RD; Haraden, BM; Gage, BF; Woodward, RS; Rubin, BG; Botney, MD
      Criteria for outpatient management of proximal lower extremity deep venousthrombosis

      CHEST
    80. Bara, L; Planes, A; Samama, MM
      Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery

      BRITISH JOURNAL OF HAEMATOLOGY
    81. Checketts, MR; Wildsmith, JAW
      Central nerve block and thromboprophylaxis - is there a problem?

      BRITISH JOURNAL OF ANAESTHESIA
    82. Etchells, E; McLeod, RS; Geerts, W; Barton, P; Detsky, AS
      Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery

      ARCHIVES OF INTERNAL MEDICINE
    83. Gould, MK; Dembitzer, AD; Sanders, GD; Garber, AM
      Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A cost-effectiveness analysis

      ANNALS OF INTERNAL MEDICINE
    84. Gould, MK; Dembitzer, AD; Doyle, RL; Hastie, TJ; Garber, AM
      Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A meta-analysis of randomized, controlled trials

      ANNALS OF INTERNAL MEDICINE
    85. Dunn, AS; Coller, B
      Outpatient treatment of deep vein thrombosis: Translating clinical trials into practice

      AMERICAN JOURNAL OF MEDICINE
    86. Rydberg, EJ; Westfall, JM; Nicholas, RA
      Low-molecular-weight heparin in preventing and treating DVT

      AMERICAN FAMILY PHYSICIAN
    87. DETOURNAY B; PLANES A; VOCHELLE N; FAGNANI F
      COST-EFFECTIVENESS OF A LOW-MOLECULAR-WEIGHT HEPARIN IN PROLONGED PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER TOTAL HIP-REPLACEMENT

      PharmacoEconomics
    88. Bartholomew, JR; Kottke-Marchant, K
      Monitoring anticoagulation therapy in patients with the lupus anticoagulant

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    89. HEILMANN L; TEMPELHOFF GFV; KIRKPATRICK C; SCHNEIDER DM; HOMMEL G; POLLOW K
      COMPARISON OF UNFRACTIONATED VERSUS LOW-MOLECULAR-WEIGHT HEPARIN FOR DEEP-VEIN THROMBOSIS PROPHYLAXIS DURING BREAST AND PELVIC CANCER-SURGERY - EFFICACY, SAFETY, AND FOLLOW-UP

      Clinical and applied thrombosis/hemostasis
    90. HULL RD; PINEO GF
      PROPHYLAXIS OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - CURRENT RECOMMENDATIONS

      Clinical and applied thrombosis/hemostasis
    91. GIROLAMI B; PRANDONI P; ROSSI L; GIROLAMI A
      TRANSAMINASE ELEVATION IN PATIENTS TREATED WITH UNFRACTIONATED HEPARIN OR LOW-MOLECULAR-WEIGHT HEPARIN FOR VENOUS THROMBOEMBOLISM

      Clinical and applied thrombosis/hemostasis
    92. MARTINEAU P; TAWIL N
      LOW-MOLECULAR-WEIGHT HEPARINS IN THE TREATMENT OF DEEP-VEIN THROMBOSIS

      The Annals of pharmacotherapy
    93. Kakkar, VV; De Lorenzo, F
      Prevention of venous thromboembolism in general surgery

      BAILLIERES CLINICAL HAEMATOLOGY
    94. Pineo, GF; Hull, RD
      Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism

      BAILLIERES CLINICAL HAEMATOLOGY
    95. Kakkar, AK; de Lorenzo, F; Pineo, GF; Williamson, RCN
      Venous thromboembolism and cancer

      BAILLIERES CLINICAL HAEMATOLOGY
    96. LEU JG; LIOU HH; WU SC; YANG WC; HUANG TP; WU SC
      LOW-MOLECULAR-WEIGHT HEPARIN IN DIABETIC AND NONDIABETIC HYPERCHOLESTEROLEMIC PATIENTS RECEIVING LONG-TERM HEMODIALYSIS

      Journal of the Formosan Medical Association
    97. STOCKELBERG D; HANSSON E; JONSON T
      TREATMENT OF DEEP-VEIN THROMBOSIS WITH LOW-MOLECULAR-WEIGHT HEPARIN AT PATIENTS HOME

      Journal of thrombosis and thrombolysis
    98. JEANDEL C; BLAIN H
      VENOUS THROMBOEMBOLISM IN ELDERLY SUBJECTS - TREATMENT

      La Presse medicale
    99. HULL RD; PINEO GF
      LOW-MOLECULAR-WEIGHT HEPARIN IN TREATMENT OF VENOUS THROMBOEMBOLISM -AN EMERGING THEME

      International angiology
    100. KIRCHMAIER CM; WOLF H; SCHAFER H; EHLERS B; BREDDIN HK
      EFFICACY OF A LOW-MOLECULAR-WEIGHT HEPARIN ADMINISTERED INTRAVENOUSLYOR SUBCUTANEOUSLY IN COMPARISON WITH INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS

      International angiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 04:54:23